Schedule 13G ownership disclosure
NLS PHARMACEUTICS LTD
Security class unavailable · CUSIP: H57830103
Event date: 2021-01-29
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001387131-21-001754
- Form type
- SC 13G
- Filer
- HIRSCHMAN ORIN
- CIK
- CIK 1131362
- Filed
- Feb 04, 2021
- Reporting period
- Jan 29, 2021
- Description
- Schedule 13G beneficial ownership